8.995
전일 마감가:
$8.52
열려 있는:
$8.41
하루 거래량:
245.17K
Relative Volume:
1.53
시가총액:
$182.03M
수익:
$56.13M
순이익/손실:
$-14.67M
주가수익비율:
-12.16
EPS:
-0.74
순현금흐름:
$-9.13M
1주 성능:
+10.21%
1개월 성능:
+22.24%
6개월 성능:
+27.45%
1년 성능:
+68.42%
Journey Medical Corp Stock (DERM) Company Profile
명칭
Journey Medical Corp
전화
480-434-6670
주소
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
DERM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
DERM
Journey Medical Corp
|
8.9625 | 224.16M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
124.80 | 63.97B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.58 | 42.40B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.339 | 41.77B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.39 | 23.54B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
437.66 | 18.89B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | H.C. Wainwright | Buy |
| 2025-07-30 | 재개 | B. Riley Securities | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-28 | 재개 | ROTH MKM | Buy |
| 2021-12-07 | 개시 | B. Riley Securities | Buy |
Journey Medical Corp 주식(DERM)의 최신 뉴스
Detecting price anomalies in Journey Medical Corporation with AIWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Can Journey Medical Corporation stock attract ESG capital inflowsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Journey Medical Corporation (NASDAQ:DERM) Given Average Rating of "Hold" by Brokerages - MarketBeat
Can a trend reversal in Journey Medical Corporation lead to recoveryPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Health Equity - AstraZeneca
Why Journey Medical Corporation stock is recommended by analysts2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Heatmap analysis for Journey Medical Corporation and competitorsJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Analyzing Journey Medical Corporation with multi timeframe chartsOil Prices & Short-Term High Return Ideas - newser.com
Price momentum metrics for Journey Medical Corporation explainedJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
How Journey Medical Corporation stock reacts to Fed rate cuts2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Will Quipt Home Medical Corp. stock outperform value stocksWall Street Watch & Daily Stock Momentum Reports - Fundação Cultural do Pará
Will Vivani Medical Inc. stock beat EPS estimates2025 Macro Impact & Weekly Chart Analysis and Trade Guides - fcp.pa.gov.br
Short interest data insights for Journey Medical CorporationJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Published on: 2025-10-27 18:20:54 - fcp.pa.gov.br
How Netflix Inc. stock performs in weak economyJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - fcp.pa.gov.br
Automated trading signals detected on Journey Medical CorporationPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com
Using RSI to spot recovery in Journey Medical CorporationPortfolio Value Summary & Advanced Swing Trade Entry Alerts - newser.com
Will Journey Medical Corporation stock see insider buying2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Volatility clustering patterns for Journey Medical CorporationNew Guidance & AI Driven Stock Movement Reports - newser.com
Journey Medical (NASDAQ:DERM) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Journey Medical’s Emrosi shows superior efficacy for rosacea - Investing.com
Houston Physician Dr. Rodolfo Giraldi Establishes National Scholarship to Cultivate the Next Generation of Medical Practitioners - Cantech Letter
Journey Medical Corporation Announces FDA Approval and Efficacy Results of Emrosi for Rosacea Treatment at 2025 Fall Clinical Dermatology Conference - Quiver Quantitative
Journey Medical (NASDAQ: DERM) Phase 3 pooled data: Emrosi cut lesions by 19.2 - Stock Titan
Fortress Biotech, Inc. (FBIO) Stock Price, News, Quote & History - Yahoo
Journey Medical Corp (DERM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):